Abstract Aims Ramadan fasting poses challenges for patients with type 2 diabetes mellitus (T2DM) due to increased risks of hypoglycemia and metabolic fluctuations. Tirzepatide, a dual GIP/GLP‐1 receptor agonist, has shown marked efficacy in glycemic control and weight reduction.
Muhammad Hafizur Rahman +11 more
wiley +1 more source
Alteraciones en el metabolismo de la glucosa en estado de resistencia a insulina y diabetes tipo 2: acción normalizadora del GLP-1 y de la Exedina -4 [PDF]
Tesis doctoral inédita. Universidad Autónoma de Madrid, Facultad de Ciencias, Departamento de Biología.
Moreno Pérez, Paola
core +1 more source
The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist. [PDF]
Cho YK, La Lee Y, Jung CH.
europepmc +1 more source
Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice. [PDF]
Liskiewicz A +30 more
europepmc +1 more source
The Role of Glucose-Dependent Insulinotropic Polypeptide (GIP) in Bone Metabolism. [PDF]
Lin A +8 more
europepmc +1 more source
The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas. [PDF]
Dalle Nogare M +9 more
europepmc +1 more source
Tirzepatide and Weight Management
Tirzepatide is a once-weekly dual agonist, that acts on glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors.
Vishal R. Tandon, Annil Mahajan
doaj
Sugar type and route of delivery influence insulin and glucose-dependent insulinotropic polypeptide responses in rats. [PDF]
Nisi AV +7 more
europepmc +1 more source
Impact of dipeptidyl peptidase-4 inhibitors on glucose-dependent insulinotropic polypeptide in type 2 diabetes mellitus: a systematic review and meta-analysis. [PDF]
Chai S +7 more
europepmc +1 more source

